Heather M. Froggatt - Concepedia

Author

Heather M. Froggatt

Also Known As

Bera, Asim K, Heather M. Froggatt, Liang, Yan

Publications

620

Citations

H-Index

Concepts

All Affiliations

Heather M. Froggatt is an author at Duke University specializing in immunodominance, viral immunity, and vaccine development.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	78
2	Immunology	1	1	78
3	Autoimmunity	1	1	78
4	Immunodominance	1	1	78
5	Innate Immunity	1	1	78

Heather M. Froggatt

Publications

575

Citations

H-Index

Page 1

	Year	Citations
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones, Science	2021	246
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL <sup>pro</sup> Reporter Assay Heather M. Froggatt, Brook E. Heaton, Nicholas S. Heaton Journal of Virology	2020	110
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance Audrey Lee, Katharine Floyd, Shengyang Wu, Nature Immunology VaccinationBcg Vaccination StimulatesVaccine DevelopmentAdaptive Immune ResponseVaccine Target	2023	78
GPER1 is required to protect fetal health from maternal inflammation Alfred T. Harding, Marisa Goff, Heather M. Froggatt, Science	2021	61
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i> Nir Drayman, Krysten A. Jones, Saara‐Anne Azizi,	2020	41
ETV7 limits antiviral gene expression and control of influenza viruses Heather M. Froggatt, Alfred T. Harding, Ryan R. Chaparian, Science Signaling	2021	39

Page 1